Ocean Biomedical

From Wikipedia, the free encyclopedia
Ocean Biomedical
IndustryPharmaceutical
FounderChirinjeev Kathuria
Headquarters
Providence, Rhode Island
,
United States
ProductsMalaria vaccine and others

Ocean Biomedical is an American biopharmaceutical company based in Providence, Rhode Island. It was originally "spun off" from a Brown University bioscience project and was founded by Indian-American scientist Chirinjeev Kathuria and Jack Elias, who was Dean of Biology and Medicine of Brown University's Alpert Medical School at the time.[1]

History[]

In January 2019,[2] Chirinjeev Kathuria co-founded Ocean Biomedical[3] in Rhode Island, United States.[4][5] The company was also co-founded by Jack Elias, who was Dean of Medicine at Brown University at the time,[6] but currently works as a senior health advisor at Brown.[7] Ocean Biomedical started off as a Brown University biotech "spin-off."[8] The biopharmaceutical company is currently based in Province, Rhode Island.[9] As of 2021, the CEO of the company is Elizabeth Ng.[10] The company works with scientists and research institutions around the world on the research and development projects for new medicines.[11]

In 2021, Ocean Biomedical announced plans to go public[8] and filed for a $100 million IPO.[12]

Areas[]

Ocean Biomedical has worked in areas such as non-small cell lung cancer[13] and pulmonary fibrosis.[12][14]

Vaccines[]

Further information: Malaria vaccine

Ocean Biomedical has worked on developing vaccines for tropical diseases such as malaria, as well as for emerging diseases like COVID-19.[15] In 2020, the company announced the discovery of a malaria vaccine.[16][17][18][19][20]

Affiliations and partnerships[]

Ocean Biomedical also has partnered with scientists such as:[21]

Scientific advisors include Roy Herbst, Wafik el-Deiry, Erol Fikrig, and William H. Koster.[10]

References[]

  1. ^ a b "Dr. Jack A. Elias, 25 over Fifty-five". 23 August 2019.
  2. ^ "UpHealth, Inc. - Governance - Board of Directors - Person Details". investors.uphealthinc.com.
  3. ^ "chirinjeev-kathuria". ocean biomedical.
  4. ^ "A Stanford lab's drug could be Covid's worst enemy and key to this company's IPO". www.bizjournals.com. Retrieved 2021-07-13.{{cite web}}: CS1 maint: url-status (link)
  5. ^ "A Stanford lab's drug could be Covid's worst enemy and key to this company's IPO". www.bizjournals.com. 2021-06-10. Retrieved 2021-06-29.{{cite web}}: CS1 maint: url-status (link)
  6. ^ Lahmers, Abbie. "Neighborhood News: A space made available to Providence's neighborhood associations free of charge". Providence Media.
  7. ^ "Jack Elias to transition to senior health advisor at Brown, will leave role as medical school dean". Brown University.
  8. ^ a b "Ocean Biomedical, a Brown University bioscience 'spin-off,' plans to go public - The Boston Globe". BostonGlobe.com.
  9. ^ "Bloomberg". www.bloomberg.com.
  10. ^ a b "Team". ocean biomedical.
  11. ^ SEC. "Ocean Biomedical, Inc. IPO Investment Prospectus S-1". SEC.report. Retrieved 2021-07-13.
  12. ^ a b "Preclinical biotech Ocean Biomedical files for a $100 million IPO". Renaissance Capital.
  13. ^ Wakuda, Kazushige; Yamaguchi, Hiroyuki; Kenmotsu, Hirotsugu; Fukuda, Minoru; Takeshita, Masafumi; Suetsugu, Takayuki; Kirita, Keisuke; Ebi, Noriyuki; Hataji, Osamu; Miura, Satoru; Chibana, Kenji; Okamoto, Isamu; Yoshimura, Kenichi; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki; Sugio, Kenji (May 1, 2020). "A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)". BMC Cancer. 20 (1): 370. doi:10.1186/s12885-020-06874-6. PMC 7195707. PMID 32357848.
  14. ^ "science". ocean biomedical.
  15. ^ "coronavirus: US based company headed by NRI aims for Covid-19 vaccine - Times of India". The Times of India.
  16. ^ "Groundbreaking malaria vaccine discovery". April 22, 2020.
  17. ^ "Punjab NRI's company to try its new malaria vaccine on Covid-19 patients | Chandigarh News - Times of India". The Times of India.
  18. ^ "Immune children aid malaria vaccine hunt". BBC News. May 22, 2014.
  19. ^ Raj, Dipak K.; Nixon, Christian P.; Nixon, Christina E.; Dvorin, Jeffrey D.; DiPetrillo, Christen G.; Pond-Tor, Sunthorn; Wu, Hai-Wei; Jolly, Grant; Pischel, Lauren; Lu, Ailin; Michelow, Ian C.; Cheng, Ling; Conteh, Solomon; McDonald, Emily A.; Absalon, Sabrina; Holte, Sarah E.; Friedman, Jennifer F.; Fried, Michal; Duffy, Patrick E.; Kurtis, Jonathan D. (May 23, 2014). "Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection". Science. 344 (6186): 871–877. Bibcode:2014Sci...344..871R. doi:10.1126/science.1254417. PMC 4184151. PMID 24855263.
  20. ^ "New Malaria Vaccine Shows Promise in Mice". www.science.org.
  21. ^ "partnerships". ocean biomedical.
  22. ^ "Brown Alpert Medical School Malaria Expert Kurtis on Gearing Up for Phase One Vaccine Trials LIVE". GoLocalProv.

External links[]

Retrieved from ""